Stopped: Principal Investigator medical \& maternity leave
Generalized anxiety disorder (GAD) is a debilitating condition involving excessive and uncontrollable worry and anxiety. Difficulty tolerating the uncertainties of life, known as intolerance of uncertainty (IU), has been shown to be key in the development and maintenance of GAD symptoms. A new, streamlined cognitive-behavioural treatment that targets IU has been shown to be effective in at reducing GAD symptoms, IU, and general psychopathology when delivered one-on-one with a therapist, as shown in a recently published pilot study. The individual format of this treatment is now being evaluated in a randomized controlled trial (RCT). The overall objective of this study is to pilot test a group version of the treatment protocol to determine if a future RCT of this group treatment is both warranted and feasible. We will also conduct a preliminary investigation into the group treatment's efficacy. A total of two pilot groups (N = 12-20) will be conducted with participants recruited from two clinical hospital sites in Winnipeg, Manitoba, Canada. The group treatment protocol will be delivered over the course of 12 weekly therapy sessions. Participants will complete assessment measures at pretreatment, posttreatment, and at a 3-month follow-up point. All assessments and treatment sessions will be conducted virtually via videoconferencing platform due to ongoing COVID-19 pandemic restrictions.
Age range
18 Years – 89 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
MINI International Neuropsychiatric Interview
Timeframe: Pretreatment (prior to the intervention).
MINI International Neuropsychiatric Interview
Timeframe: Posttreatment (after completing final session of the treatment intervention)
MINI International Neuropsychiatric Interview
Timeframe: 3-month follow-up
Worry and Anxiety Questionnaire
Timeframe: Pretreatment (prior to the intervention).
Worry and Anxiety Questionnaire
Timeframe: Posttreatment (after completing final session of the treatment intervention)
Worry and Anxiety Questionnaire
Timeframe: 3-month follow-up
Intolerance of Uncertainty Scale
Timeframe: Pretreatment (prior to the intervention).
Intolerance of Uncertainty Scale
Timeframe: Posttreatment (after completing final session of the treatment intervention)
Intolerance of Uncertainty Scale
Timeframe: 3-month follow-up